Skip to main content

Table 1 Clinical characteristics of patients (n = 16)

From: Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19

Male 11 (68.8%)
Median age, years (IQR) 55 (40.5–71.5)
Median duration from onset of symptoms to hospitalization, days (IQR) 7 (3.25–9)
Underlying disease
 Diabetes mellitus 4 (25%)
 Hypertension 2 (12.5%)
 Heart disease 2 (12.5%)
Treatment
 Azithromycin 11 (68.8%)
 Favipiravir 11 (68.8%)
 Nafamostat 12 (75%)
 Tocilizumab 7 (43.7%)
Disease severity
 Mild 6 (37.5%)
 Severe 10 (62.5%)
PaO2/FiO2 ratio
 > 350 6 (37.5%)
 200–300 5 (31.25%)
 150–200 3 (18.75%)
 < 150 2 (12.5%)
  1. IQR interquartile range, PaO2/FiO2ratio ratio of arterial partial pressure of oxygen to the fraction of inspired oxygen